AAVance Gene Therapy Trial Data Highlight Importance of Early Dosing
Children with Sanfilippo syndrome type A who were treated with the investigational gene therapy LYS-SAF302 before 2.5 years of age showed improvements in cognitive development compared to what is expected without treatment, according to top-line data from the Phase 2/3 AAVance clinical trial. However, the trial did not meet its…